Press Releases

Business Highlights

Recognized for track record of excellence, professionalism and demonstrated integrity in the legal field

Expands responsibility to include Americas region

S&P Global upgrades the Company's issuer credit default rating to BB-/Positive

- Revenue of $1.48 billion, declining 3.5%; organic decline of 2.0%

Increased investment in bioprocessing infrastructure furthers biologics innovation and improved efficiencies in bioproduction

Avantor helps power innovation in the life sciences and advanced technologies industries from discovery to delivery

Fitch upgrades the company's long-term issuer default rating to BB-/Stable

- Revenue of $1.52 billion, increase of 2.6%; organic growth of 4.1%

The Avantor Foundation donates $100K to Charities Aid Foundation of America (CAF America) to support hospitals and relief organizations globally

New high purity resin advances bioprocessing and brings choice and efficiencies to mAbs production workflow processes and protocols

- Net sales $1.52 billion, net income $70.6 million, adjusted EBITDA $263.6 million

Avantor's latest innovation and customer support center brings bioprocessing expertise, related technology and specialized training programs closer to biopharma companies in China

Avantor's in-line dilution systems to be installed at NIBRT's prestigious bioprocessing research and training facility in Dublin, adding to their full complement of technology

- Net sales of $1.50 billion, net income of $22.1 million, adjusted EBITDA of $250.8 million

- Net sales of $1.53 billion, up 4% (6% on an organic basis)